Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,deferredLongTermLiab,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,currency,exchange,marketCap,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,market,exchangeDataDelayedBy,shortName,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,EKDHF,43707000,457555008,854000,,4553500,552000,3551500,3949500,11254000,4652000,4652000,-38000,-17000,,,,931500,19465500,14813500,8211500,-98500,,3622000,3551500,9543000,200000,23065000,77648000,3110000,11149000,101265000,4550000,63516000,2636000,24398000,9382000,3124000,21913000,19416000,14000,185000,9382000,13639000,43953000,6608000,12683000,323000,8487000,2408000,1930000,-93500,1430000,-180000,-2403500,54500,2509000,-392500,3875000,1099500,12000,-2275000,-250500,-726000,-3000,246000,-222000,24537000,en-US,US,EQUITY,False,Delayed Quote,1.0563,1629385515,0.0,1.0563,1.0563,1.0563,1,USD,PNK,523173792,-14400000,False,False,REGULAR,4,0.0,1.0563 - 1.0563,us_market,0,EKF DIAGNOSTICS HOLDINGS PLC,1.0563,0.0,0.0,0,0,finmb_8952281,Other OTC,EKF Diagnostics Holdings plc,GBP,0,0,0.7263,2.200909,0.33 - 1.0563,0.0,0.0,0.33,1.0563,0.011,32.009094,0.010413708,0.033,0.171,0.7,0.35630006,0.50900006,0.6862222,0.37007785,0.5392974,6.177193,15,America/New_York,EDT,0.82,,,1.0563,0.33,0.7,0.6862,,,457.56M,,433.08M,5.42%,64.30%,,,,,,,,0.01,1.04%,,,,,,,"Dec 30, 2020","Dec 30, 2020",17.03%,23.92%,10.36%,15.24%,65.26M,0.14,65.80%,37.42M,19.49M,11.11M,0.0330,202.00%,21.91M,0.05,1.58M,2.02,2.26,0.17,13.81M,16.27M,Value,CF64 2EZ,,356,"EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, it offers Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; rapid test detectors; QuStick Strep A for Strep A infection treatment; RaPET Serology immunoassay kits; LiquiColor biomarkers; and kits and other services related to COVID-19, as well as reagents, calibrators, standards, and controls. Additionally, it offers contract manufacturing services, as well as distributes third party company's products. It sells its products directly to hospitals, laboratories, and government agencies, as well as through a network of distributors. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.",Cardiff,44 29 2071 0570,1609372800,United Kingdom,http://www.ekfdiagnostics.com,86400,Avon House,44 29 2070 5715,,19 Stanwell Road Penarth
t-1,EKDHF,43707000,457555008,854000,,4553500,552000,3551500,3949500,11254000,4652000,4652000,-38000,-17000,,,,931500,19465500,14813500,8211500,-98500,,3622000,3551500,9543000,200000,23065000,77648000,3110000,11149000,101265000,4550000,63516000,2636000,24398000,9382000,3124000,21913000,19416000,14000,185000,9382000,13639000,43953000,6608000,12683000,323000,8487000,2408000,1930000,-93500,1430000,-180000,-2403500,54500,2509000,-392500,3875000,1099500,12000,-2275000,-250500,-726000,-3000,246000,-222000,24537000,en-US,US,EQUITY,False,Delayed Quote,1.0563,1629385515,0.0,1.0563,1.0563,1.0563,1,USD,PNK,523173792,-14400000,False,False,REGULAR,4,0.0,1.0563 - 1.0563,us_market,0,EKF DIAGNOSTICS HOLDINGS PLC,1.0563,0.0,0.0,0,0,finmb_8952281,Other OTC,EKF Diagnostics Holdings plc,GBP,0,0,0.7263,2.200909,0.33 - 1.0563,0.0,0.0,0.33,1.0563,0.011,32.009094,0.010413708,0.033,0.171,0.7,0.35630006,0.50900006,0.6862222,0.37007785,0.5392974,6.177193,15,America/New_York,EDT,0.82,,,1.0563,0.33,0.7,0.6862,,,457.56M,,433.08M,5.42%,64.30%,,,,,,,,0.01,1.04%,,,,,,,"Dec 30, 2020","Dec 30, 2020",17.03%,23.92%,10.36%,15.24%,65.26M,0.14,65.80%,37.42M,19.49M,11.11M,0.0330,202.00%,21.91M,0.05,1.58M,2.02,2.26,0.17,13.81M,16.27M,Value,CF64 2EZ,,356,"EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, it offers Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; rapid test detectors; QuStick Strep A for Strep A infection treatment; RaPET Serology immunoassay kits; LiquiColor biomarkers; and kits and other services related to COVID-19, as well as reagents, calibrators, standards, and controls. Additionally, it offers contract manufacturing services, as well as distributes third party company's products. It sells its products directly to hospitals, laboratories, and government agencies, as well as through a network of distributors. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.",Cardiff,44 29 2071 0570,1609372800,United Kingdom,http://www.ekfdiagnostics.com,86400,Avon House,44 29 2070 5715,,19 Stanwell Road Penarth
t-2,EKDHF,42327000,457555008,-154000,,3124500,472000,2005500,4484000,7456000,3154500,3154500,-28500,-21000,,,,1054000,13164500,10010000,5708500,-30000,,2070500,2005500,10950000,95000,24516000,78581000,3093000,5786000,103569000,4546000,55637000,2940000,25304000,18303000,3114000,16895000,20433000,21000,188000,18303000,14272000,35584000,14345000,10545000,422000,8144000,14211000,1930000,1037500,-762000,-146000,-201000,50000,2410500,344000,3029500,1083000,14500,-2275000,-1028000,-987000,-105000,843500,-593500,15151000,en-US,US,EQUITY,False,Delayed Quote,1.0563,1629385515,0.0,1.0563,1.0563,1.0563,1,USD,PNK,523173792,-14400000,False,False,REGULAR,4,0.0,1.0563 - 1.0563,us_market,0,EKF DIAGNOSTICS HOLDINGS PLC,1.0563,0.0,0.0,0,0,finmb_8952281,Other OTC,EKF Diagnostics Holdings plc,GBP,0,0,0.7263,2.200909,0.33 - 1.0563,0.0,0.0,0.33,1.0563,0.011,32.009094,0.010413708,0.033,0.171,0.7,0.35630006,0.50900006,0.6862222,0.37007785,0.5392974,6.177193,15,America/New_York,EDT,0.82,,,1.0563,0.33,0.7,0.6862,,,457.56M,,433.08M,5.42%,64.30%,,,,,,,,0.01,1.04%,,,,,,,"Dec 30, 2020","Dec 30, 2020",17.03%,23.92%,10.36%,15.24%,65.26M,0.14,65.80%,37.42M,19.49M,11.11M,0.0330,202.00%,21.91M,0.05,1.58M,2.02,2.26,0.17,13.81M,16.27M,Value,CF64 2EZ,,356,"EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, it offers Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; rapid test detectors; QuStick Strep A for Strep A infection treatment; RaPET Serology immunoassay kits; LiquiColor biomarkers; and kits and other services related to COVID-19, as well as reagents, calibrators, standards, and controls. Additionally, it offers contract manufacturing services, as well as distributes third party company's products. It sells its products directly to hospitals, laboratories, and government agencies, as well as through a network of distributors. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.",Cardiff,44 29 2071 0570,1609372800,United Kingdom,http://www.ekfdiagnostics.com,86400,Avon House,44 29 2070 5715,,19 Stanwell Road Penarth
t-3,EKDHF,42327000,457555008,-154000,,3124500,472000,2005500,4484000,7456000,3154500,3154500,-28500,-21000,,,,1054000,13164500,10010000,5708500,-30000,,2070500,2005500,10950000,95000,24516000,78581000,3093000,5786000,103569000,4546000,55637000,2940000,25304000,18303000,3114000,16895000,20433000,21000,188000,18303000,14272000,35584000,14345000,10545000,422000,8144000,14211000,1930000,1037500,-762000,-146000,-201000,50000,2410500,344000,3029500,1083000,14500,-2275000,-1028000,-987000,-105000,843500,-593500,15151000,en-US,US,EQUITY,False,Delayed Quote,1.0563,1629385515,0.0,1.0563,1.0563,1.0563,1,USD,PNK,523173792,-14400000,False,False,REGULAR,4,0.0,1.0563 - 1.0563,us_market,0,EKF DIAGNOSTICS HOLDINGS PLC,1.0563,0.0,0.0,0,0,finmb_8952281,Other OTC,EKF Diagnostics Holdings plc,GBP,0,0,0.7263,2.200909,0.33 - 1.0563,0.0,0.0,0.33,1.0563,0.011,32.009094,0.010413708,0.033,0.171,0.7,0.35630006,0.50900006,0.6862222,0.37007785,0.5392974,6.177193,15,America/New_York,EDT,0.82,,,1.0563,0.33,0.7,0.6862,,,457.56M,,433.08M,5.42%,64.30%,,,,,,,,0.01,1.04%,,,,,,,"Dec 30, 2020","Dec 30, 2020",17.03%,23.92%,10.36%,15.24%,65.26M,0.14,65.80%,37.42M,19.49M,11.11M,0.0330,202.00%,21.91M,0.05,1.58M,2.02,2.26,0.17,13.81M,16.27M,Value,CF64 2EZ,,356,"EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, it offers Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; rapid test detectors; QuStick Strep A for Strep A infection treatment; RaPET Serology immunoassay kits; LiquiColor biomarkers; and kits and other services related to COVID-19, as well as reagents, calibrators, standards, and controls. Additionally, it offers contract manufacturing services, as well as distributes third party company's products. It sells its products directly to hospitals, laboratories, and government agencies, as well as through a network of distributors. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.",Cardiff,44 29 2071 0570,1609372800,United Kingdom,http://www.ekfdiagnostics.com,86400,Avon House,44 29 2070 5715,,19 Stanwell Road Penarth
